Kengo Imai
About
Kengo Imai is a scholar working on Public Health, Environmental and Occupational Health, Critical Care and Intensive Care Medicine and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Kengo Imai has authored 47 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 21 papers in Critical Care and Intensive Care Medicine and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kengo Imai's work include Palliative Care and End-of-Life Issues (28 papers), Intensive Care Unit Cognitive Disorders (20 papers) and Healthcare Decision-Making and Restraints (9 papers). Kengo Imai is often cited by papers focused on Palliative Care and End-of-Life Issues (28 papers), Intensive Care Unit Cognitive Disorders (20 papers) and Healthcare Decision-Making and Restraints (9 papers). Kengo Imai collaborates with scholars based in Japan, United States and United Kingdom. Kengo Imai's co-authors include Tatsuya Morita, Masanori Mori, Naosuke Yokomichi, Yoshiyuki Kizawa, Hiroyuki Otani, Takashi Yamaguchi, Mitsunori Miyashita, Satoru Tsuneto, Ai Oishi and Hiroki Sakurai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Cancer.
In The Last Decade
Kengo Imai
43 papers receiving 415 citations
Peers
Kengo Imai
Stacy Hall United States
Tatsuya Morita Japan
Timotheos Paraskevopoulos United States
Takuya Shinjo Japan
Ellen Pace United States
Cristina Pittureri Italy
Piero Morino Italy
Alberto Alonso‐Babarro Spain
Virginia Jarvis Canada
Raúl Sala United States
Citations per year, relative to Kengo Imai Kengo Imai (= 1×)
peers
Stacy Hall
Countries citing papers authored by Kengo Imai
Since
Specialization
Citations
This map shows the geographic impact of Kengo Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kengo Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kengo Imai more than expected).
Fields of papers citing papers by Kengo Imai
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kengo Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kengo Imai. The network helps show where Kengo Imai may publish in the future.
Co-authorship network of co-authors of Kengo Imai
This figure shows the co-authorship network connecting the top 25 collaborators of Kengo Imai. A scholar is included among the top collaborators of Kengo Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kengo Imai. Kengo Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Yokomichi, Naosuke, Tatsuya Morita, Takayuki Hisanaga, et al.. (2024). Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life. Journal of Pain and Symptom Management. 67(5). 441–452.e3.
2.
Shimizu, M., Isseki Maeda, Takaomi Kessoku, et al.. (2024). The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study. Supportive Care in Cancer. 32(8). 504–504.
3.
Hasegawa, Takaaki, Masanori Mori, Takashi Yamaguchi, et al.. (2024). Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study. Journal of Palliative Medicine. 28(4). 437–445.
4.
Otani, Hiroyuki, Naosuke Yokomichi, Kengo Imai, et al.. (2024). A Novel Objective Measure for Terminal Delirium: Activity Scores Measured by a Sheet-Type Sensor. Journal of Pain and Symptom Management. 68(3). 246–254.
5.
Imai, Kengo, Tatsuya Morita, Masanori Mori, et al.. (2023). Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. Journal of Pain and Symptom Management. 65(6). 479–489.
6.
Mori, Masanori, Takashi Yamaguchi, Kozue Suzuki, et al.. (2023). Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. Journal of Pain and Symptom Management. 66(2). e177–e184.
7.
Maeda, Sayaka, Tatsuya Morita, Naosuke Yokomichi, et al.. (2023). Continuous Deep Sedation for Psycho-Existential Suffering: A Multicenter Nationwide Study. Journal of Palliative Medicine. 26(11). 1501–1509.
8.
Mori, Masanori, Takashi Yamaguchi, Kozue Suzuki, et al.. (2022). The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study. Cancer Medicine. 12(5). 5397–5408.
9.
Morita, Tatsuya, Kengo Imai, Masanori Mori, Naosuke Yokomichi, & Satoru Tsuneto. (2022). Defining “Continuous Deep Sedation” Using Treatment Protocol: A Proposal Article. SHILAP Revista de lepidopterología. 3(1). 8–15.
10.
Imai, Kengo, Tatsuya Morita, Naosuke Yokomichi, et al.. (2022). Association of the RASS Score with Intensity of Symptoms, Discomfort, and Communication Capacity in Terminally Ill Cancer Patients Receiving Palliative Sedation: Is RASS an Appropriate Outcome Measure?. SHILAP Revista de lepidopterología. 3(1). 47–54.
11.
Mori, Masanori, Takashi Kawaguchi, Kengo Imai, et al.. (2021). Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study. Journal of Pain and Symptom Management. 62(5). 936–948.
12.
Sakurai, Hiroki, Mitsunori Miyashita, Tatsuya Morita, et al.. (2021). Comparison between patient-reported and clinician-reported outcomes: Validation of the Japanese version of the Integrated Palliative care Outcome Scale for staff. Palliative & Supportive Care. 19(6). 702–708.
13.
Inada, Shuji, Isseki Maeda, Asao Ogawa, et al.. (2021). A decision tree prediction model for a short-term outcome of delirium in patients with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R). Palliative & Supportive Care. 20(2). 153–158.
14.
Miura, Tomofumi, Eriko Satomi, Keita Tagami, et al.. (2021). Dexamethasone 8 mg for Cancer-Related Fatigue in Inpatients with Advanced Cancer Undergoing Palliative Care: A Multicenter Phase II Trial. SHILAP Revista de lepidopterología. 2(1). 316–323.
15.
Hisanaga, Takayuki, Takuya Shinjo, Kengo Imai, et al.. (2019). Clinical Guidelines for Management of Gastrointestinal Symptoms in Cancer Patients: The Japanese Society of Palliative Medicine Recommendations. Journal of Palliative Medicine. 22(8). 986–997.
16.
Imai, Kengo, Tatsuya Morita, Naosuke Yokomichi, et al.. (2017). Efficacy of two types of palliative sedation therapy defined using intervention protocols: proportional vs. deep sedation. Supportive Care in Cancer. 26(6). 1763–1771.
17.
Morita, Tatsuya, Kengo Imai, Naosuke Yokomichi, et al.. (2016). Continuous Deep Sedation: A Proposal for Performing More Rigorous Empirical Research. Journal of Pain and Symptom Management. 53(1). 146–152.
18.
Imai, Kengo, et al.. (2014). Effectiveness of the etiology-based antiemetic recommendations by a palliative care team for nausea in cancer patients. Palliative Care Research. 9(2). 108–113.
19.
Morita, Tatsuya, et al.. (2013). Identifying factors to differentiate neoplastic fever from infection retrospectively among terminally ill cancer patients. Palliative Care Research. 8(2). 273–279.
20.
Imai, Kengo, et al.. (2011). Effectiveness and long term safety of gabapentin in the management of neuropathic pain of terminally-ill cancer patients. Palliative Care Research. 6(1). 101–108.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Stacy Hall Breakdown of academic impact, for papers by Tatsuya Morita Breakdown of academic impact, for papers by Timotheos Paraskevopoulos Breakdown of academic impact, for papers by Takuya Shinjo Breakdown of academic impact, for papers by Ellen Pace Breakdown of academic impact, for papers by Cristina Pittureri Breakdown of academic impact, for papers by Piero Morino Breakdown of academic impact, for papers by Alberto Alonso‐Babarro Breakdown of academic impact, for papers by Virginia Jarvis Breakdown of academic impact, for papers by Raúl Sala